SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : ATCO -- Breakthrough in Sound Reproduction
ATCO 15.480.0%Mar 28 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: SunAge who started this subject12/12/2002 2:19:26 PM
From: Savant   of 2062
 
RT--Tinnitus/Ultrasound--go RinTinTin--Hearing Innovations Announces Patented HiSonic-TRD Tinnitus Relief Device Now

Available to Consumers

Business Editors & Health/Medical Writers

FARMINGDALE, N.Y.--(BUSINESS WIRE)--Dec. 12, 2002--Hearing
Innovations:

First and Only Device to Use Low-Level Ultrasound to Treat and Relieve
Severe Tinnitus Symptoms; More than 50 Million Tinnitus Sufferers
Nationwide Hear "Ringing In The Ears"; 12 Million Suffer
from Severe Tinnitus

Hearing Innovations Incorporated announced today that its tinnitus
relief device -the HiSonic-TRD- is now available to tinnitus
sufferers.
This breakthrough technology is the first and only device to use
low-level ultrasound to treat and relieve tinnitus symptoms. Hearing
Innovations received a U.S. patent for the exclusive and protected
right for the use of ultrasound to treat individuals with tinnitus.
The company received 510(k) marketing clearance for the HiSonic-TRD
earlier this year from the U.S. Food and Drug Administration (FDA)
based on positive results from its clinical safety and efficacy study
and has been involved in the manufacturing process in recent months in
anticipation of the launch of this announcement.
The HiSonic-TRD is intended to be used for tinnitus habituation
therapy and tinnitus masking therapy. The HiSonic-TRD provides
immediate, effective and safe relief from the severe symptoms of
tinnitus through bone-conducted ultrasound.
Tinnitus is the term for noises which are heard "in the ears" or
"in the head." Often described as a "ringing," these noises are also
described as buzzing, whistling, hissing, pulsing or other sounds that
do not come from an external source. According to The American
Tinnitus Association, more than 50 million American adults have
tinnitus to some degree. Of that number, 12 million suffer from severe
tinnitus, causing sufferers to seek medical attention for loss of
concentration, sleep problems and psychological distress. Many
patients are so seriously debilitated that they cannot function on a
normal, day-to-day basis due to extreme distress, depression and, in
the worst cases, suicidal tendencies.
Ken Coviello, CEO of Hearing Innovations, states, "Tinnitus is a
debilitating condition for millions of sufferers. We believe that the
HiSonic-TRD will provide many patients with significant relief from
their severe symptoms."
Hearing Innovations' HiSonic-TRD is now being made available to
consumers by prescription from their licensed audiologist,
Otolaryngologist (Ear, Nose & Throat physician) or local hearing
center.
Tinnitus (pronounced tin-night-us" or "tin-nit-us") has a range of
causes. While there are many types of treatments that have been used
on patients, many sufferers have not yet been able to find a treatment
that successfully treats their affliction. In fact, despite the
widespread incidence of tinnitus, Hearing Innovations believes that
limited attention has been focused on this problem.
The exclusive manufacturer for Hearing Innovations' HiSonic-TRD is
Misonix Incorporated (NASDAQ NM: MSON), a company that develops,
manufactures and/or markets medical, scientific and industrial
ultrasonic and air pollution systems and also owns a minority equity
position in Hearing Innovations Incorporated.
Hearing Innovations has conducted safety and efficacy studies at
the University of Oregon Tinnitus Clinic, the University of Illinois
Bioacoustics Research Laboratory and the University at Buffalo
Speech-Language and Hearing Clinic.
Since 2000, Hearing Innovations has been marketing a
similarly-named product, the HiSonic, a non-invasive ultrasonic bone
conduction hearing device for the profoundly deaf.
Hearing Innovations Incorporated is a privately held corporation
located at 1938 New Highway in Farmingdale, New York. For more
information about the HiSonic-TRD, call Hearing Innovations at (631)
927-9100 or e-mail them at info@hearinginnovations.com.

Product photo available upon request.

--30--kk/ny*

CONTACT: The Jarchin Group
Andrew Jarchin, 631/427-7188
info@jarchin.com
or
Hearing Innovations
Ken Coviello, 631/927-9100
info@hearinginnovations.com

KEYWORD: NEW YORK
INDUSTRY KEYWORD: MEDICAL MEDICAL DEVICES PRODUCT
SOURCE: Hearing Innovations

Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.
URL: businesswire.com





Dec-12-2002 19:01 GMT
Source BW
Categories:
MST/R/US/NY MST/I/MTC MST/I/MTC
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext